← Open Payments lookup

MICHELLE CHAMBRONE: Open Payments

NPI 1295728939 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,280 in 112 payments from 21 companies in 2025. Trend: 2023 $2,418 · 2024 $2,476 · 2025 $2,280

Food & beverage: $2,280
CompanyPaymentsAmount
ABBVIE INC.33$612
Novo Nordisk Inc5$207
AstraZeneca Pharmaceuticals LP9$193
Amgen Inc.14$186
PFIZER INC.10$184
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Lilly USA, LLC7$121
Astellas Pharma US Inc5$111
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$98
Abbott Laboratories4$80

Products named: VRAYLAR, QULIPTA, Ozempic, OTEZLA, CAPLYTA, Veozah, UBRELVY, MOUNJARO.

Industry payments across NY — which companies pay providers there.